Time trends of ovarian cancer incidence in China.

The aim of this study was to examine the trend of ovary cancer incidence from 1999 to 2010 in China and predict the burden up to 2020. Crude incidence, age specific incidence and age-adjusted incidence rates were calculated. Joinpoint regression was performed to obtain estimated annual percentages and Bayesian age-period- cohort modeling was used to predict the incidence rate until the year 2020. In China, the crude rate of ovary cancer was 7.91/100,000 and the age-adjusted rate was 5.35/100,000 overall during period 1999-2010. The rates in urban regions were higher than in rural regions. A significant rising trend during 1999-2006 was followed by a drop during 2006-2010 in age-adjusted rates for urban females. In contrast, constant rise was observed in rural women. The decrease in ovary cancer of urban areas tended to be restricted to women aged 50 years and younger. In contrast, increases of ovary cancer in rural areas appeared in virtually all age groups. Although the age-adjusted incidence rate for ovary cancer was predicted to be reduced after year 2011, the crude rate was likely to be relative stable up to 2020. The burden of ovary cancer in China will continue to be relative stable due to the aging population.

[1]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[2]  K. P. Phillips,et al.  Risk Factors for Ovarian Cancer: An Overview with Emphasis on Hormonal Factors , 2008, Journal of toxicology and environmental health. Part B, Critical reviews.

[3]  J. W. Kim,et al.  Current status of gynecological cancer in China. , 2009, Journal of gynecologic oncology.

[4]  D. Qiu,et al.  Comparison of time trends in liver cancer incidence (1973-1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol. IV-VIII. , 2007, Japanese journal of clinical oncology.

[5]  T. Marugame,et al.  Comparison of time trends in ovary cancer incidence (1973-1997) in East Asia, Europe, and the USA, from Cancer Incidence in Five Continents Vols IV VIII. , 2007, Japanese journal of clinical oncology.

[6]  X. Shu,et al.  Incidence trends for cancers of the breast, ovary, and corpus uteri in urban Shanghai, 1972–89 , 1993, Cancer Causes & Control.

[7]  F. Mowat,et al.  An international assessment of ovarian cancer incidence and mortality. , 2013, Gynecologic oncology.

[8]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[9]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[10]  P. Brennan,et al.  Recent trends and future directions for lung cancer mortality in Europe , 2002, British Journal of Cancer.

[11]  F. Bray,et al.  Ovarian cancer in Europe: Cross‐sectional trends in incidence and mortality in 28 countries, 1953–2000 , 2005, International journal of cancer.

[12]  K. Wong,et al.  Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study. , 2012, Hong Kong medical journal = Xianggang yi xue za zhi.

[13]  Volker Schmid,et al.  Bayesian Age-Period-Cohort Modeling and Prediction - BAMP , 2007 .